CINJOG 080811: Phase II trial of Atorvastatin (Lipitor) and Celecoxib in Patients with Hormone-Dependent Prostate-Specific Antigen (Stage D0).
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Atorvastatin (Primary) ; Celecoxib (Primary)
- Indications Prostate cancer
- Focus Biomarker; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 02 Feb 2017 Status changed from active, no longer recruiting to completed.
- 19 Jan 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.